Pfizer is to begin producing a key ingredient for its COVID-19 vaccine at an Irish facility for the first time, the U.S. drugmaker said in a statement on Wednesday.An existing Pfizer facility at Grange Castle in Dublin will produce “mRNA drug substance” with output to begin by the end of the year, the statement said.
Up to $40m will be invested in Grange Castle and an additional 75 roles will be recruited
Irish Prime Minister Micheál Martin welcomed the development in a Twitter post as “great news… that puts Ireland at the heart of the EU’s fight against the pandemic”.
In a statement, it said: “As such, Pfizer is now bringing on additional European-based facility to be a part of the global Pfizer-BioNTech Covid-19 vaccine supply chain network and Grange Castle (Ireland) will contribute to the worldwide supply of the vaccine.